Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives
Cholangiocarcinoma is a highly heterogeneous malignant tumor, including intrahepatic cholangiocarcinoma, hepatoportal cholangiocarcinoma and distal cholangiocarcinoma. Its incidence is increasing worldwide and currently accounts for approximately 15% of all primary liver cancers and 3% of all gastro...
Saved in:
| Main Authors: | Yi Wang, Yike Li, Zhong Liang, Yuqiao Zhang, Tong Li, Chenjun Tian, Jinyu Zhao, Boru Jin, Jie Cao, Yanyan Lin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Cell and Developmental Biology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2025.1616064/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of bile preparation for liquid biopsy in cholangiocarcinoma focusing on circulating tumor DNA and protein stability
by: Jin-Yi Han, et al.
Published: (2025-04-01) -
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium
by: Andrew G. Hadd, et al.
Published: (2025-03-01) -
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
by: Nicola Fusco, et al.
Published: (2025-06-01) -
Circulating Tumor DNA in Primary and Secondary Liver Cancers: A Comprehensive Review
by: Hanna Hong, et al.
Published: (2025-06-01) -
The role of circulating tumor DNA in melanomas of the uveal tract
by: Mohammed Zeeshan Zameer, et al.
Published: (2024-12-01)